SPAIN | ![]() |
advanced in vitro cell technologies s.l., a biotech nanomedicine company, engages in the development of drugs through the search for new applications for already-known molecules, and services and reagents. it also develops and markets in vitro cell models with a regulatory and/or predictive value. in addition, the company offers researchservices; safety assessment of cosmetic raw materials and finished products; vitro services for toxicological evaluation and advising; integrated and customized research for absorption, distribution, metabolism, and elimination; skin biology and cosmetics; anti-tumoural activity of compounds; anti-inflammatory activity of new compounds and cell responses to inflammatory stimuli; biocompatibility for evaluating biocompatible materials; cacoready system, an integral tool designed to optimize time and costs for intestinal absorption evaluation of compounds; cacogoblet cell model that combines the absorbent qualities of caco2 cells with a mucosecreting cell line; transportplus, a ready-to-use system for in vitro comparative absorption profiling; adipoready kit, an in vitro model for studying the toxicity of metabolites derived from the action of cytochrome p-450 isoenzymes in a ready-to-use system; and liver, lung, and human skin microsomes. advanced in vitro cell technologies s.l. was founded in 2001 and is based in barcelona, spain.